Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease
The Egyptian Journal of Hospital Medicine · 01.04.2023 · 91 (1) · 5345-5352
DOI: 10.21608/ejhm.2023.305534 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.04.2023. Verfasst von Sherif Ali Mohamed Bahnasawy und 3 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide; thus, an early and accurate diagnosis will improve the prognosis therapeutic interventions.
Aim
To assess the diagnostic value of liver fatty acid binding protein (L-FABP) for liver injury in non-alcoholic fatty liver disease (NAFLD). Patients and methods: This prospective case-control study was conducted at the Hepatology, Gastroenterology, and Infectious Diseases Clinics, Zagagzig University Hospitals, Egypt on 60 participants divided into three groups: 20 members of the NAFLD in group I had high liver enzymes, 20 members of the NAFLD in group II had normal liver enzymes and 20 members of the healthy control group in group III. L-FABP was measured in all subjects.
Results
Regarding L-FABP levels, all of the examined groups showed a significant statistical difference; group I had higher levels than groups II and III, whereas group II had higher levels than group III.
Conclusion
The diagnostic biomarker fatty acid-binding liver protein is very useful for NAFLD and a good diagnostic tool of fatty liver injury as its concentrations reflect the level invasion of fat into the liver tissue.
Zitieren
APA
Bahnasawy, S. A. M., Gammal, N. E. S. E., Attar, N. I. E., & El-Gebaly, A. M. (2023). Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease. The Egyptian Journal of Hospital Medicine, 91(1), 5345-5352. https://doi.org/10.21608/ejhm.2023.305534
Vancouver
Bahnasawy SAM, Gammal NESE, Attar NIE, El-Gebaly AM. Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease. The Egyptian Journal of Hospital Medicine. 2023;91(1):5345-5352. doi:10.21608/ejhm.2023.305534
BibTeX
@article{Bahnasawy2023,
author = {Bahnasawy, Sherif Ali Mohamed and Gammal, Nahla El Sayed El and Attar, Nahla Ibrahim El and El-Gebaly, Ahmed M.},
title = {Liver Fatty Acid-binding Protein (L-FABP) as a Diagnostic Marker for Non-alcoholic Fatty Liver Disease},
journal = {The Egyptian Journal of Hospital Medicine},
year = {2023},
volume = {91},
number = {1},
pages = {5345--5352},
doi = {10.21608/ejhm.2023.305534}
}
EUVIMED